Clinical Trial Update: M7824 in Subjects With HPV Associated Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial update for M7824 in HPV-associated malignancies completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Oropharyngeal Cancer
• Penile Cancer
• Vaginal Cancer

Drugs mentioned

• M7824 (bintrafusp alfa)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Human Papilloma Virus, Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-02-28